Wang

Wang Research Group @ UNC Wilmington

List of Publications

  1. J.B. Rowe, R.P. Flynn, H.R. Wooten, H.A. Noufer, R.A. Cancel, J. Zhang, J.A. Subramony, S. Pechenov, Y. Wang, "Submicron Aggregation of Chemically Denatured Monoclonal Antibody"Molecular Pharmaceutics, 15, 4710-4721 (2018).[PDF]
  2. J.B. Rowe, R.A. Cancel, T.D. Evangelous, R.P. Flynn, S. Pechenov, J.A. Subramony, J. Zhang, Y. Wang, "Meta-stability Gap in the Phase Diagram of Monoclonal IgG Antibody"Biophysical Journal, 113, 1750-1756 (2017).[PDF]
  3. Y. Wang, A. Lomakin, S. Kanai, R. Alex, G. B. Benedek, "Liquid−Liquid Phase Separation in Oligomeric Peptide Solutions."Langmuir, 33, 7715-7721 (2017).[PDF]
  4. G. Sun, Y. Wang, A. Lomakin, G. B. Benedek, H. E. Stanley, L. Xu, S. V. Buldyrev "The Phase Behavior Study of Human Antibody Solution Using Multi-scale Modeling"The Journal of Chemical Physics,145, 194901 (2016).[PDF]
  5. R.W. Thompson, R.F. Latypov, Y. Wang, A. Lomakin, J.A. Meyer, S. Vunnum, G. B. Benedek, "Evaluation of effects of pH and ionic strength on colloidal stability of IgG solutions by PEG-induced liquid-liquid phase separation."The Journal of Chemical Physics,145, 185101 (2016).[PDF]
  6. Y. Wang, A. Lomakin, S. Kanai, R. Alex, S. Belli, M. Donzelli, G. B. Benedek, "The molecular basis for the prolonged blood circulation of lipidated incretin peptides: peptide oligomerization or binding to serum albumin?"Journal of Controlled Release,241, 25-33 (2016).[link, free access by Nov.5]
  7. M.A. Kreutzberger, E. Tejada, Y. Wang, P.F. Almeida, "GUVs melt like LUVs: the large heat capacity of MLVs is not due to large size or small curvature."Biophysical Journal,12(2), 411-419 (2015).[PDF]
  8. Y. Wang, A. Lomakin, S. Kanai, R. Alex, G.B. Benedek, "Transformation of oligomers of lipidated peptide Induced by Change in pH."Molecular Pharmaceutics,12(2), 411-419 (2015).[PDF]
  9. Y. Wang, R.F. Latypov, A. Lomakin, J.A. Meyer, B.A. Kerwin, S. Vunnum, G.B. Benedek, "Quantitative evaluation of colloidal stability of antibody solutions using PEG-induced liquid-liquid phase separation."Molecular Pharmaceutics,11(5), 1391-1402 (2014).[PDF]
  10. Y. Wang, A. Lomakin, R.F. Latypov, J.P. Laubach, T. Hideshima, P.G. Richardson, N.C. Munshi, K.C. Anderson, G.B. Benedek, "Phase transitions in human IgG solutions."J. Chem. Phys.,139, 121904(1-9) (2013).[PDF]
  11. Y. Wang, A. Lomakin, T. Hideshima, J.P. Laubach, O.O. Ogun, P.G. Richardson, N.C. Munshi, K.C. Anderson, G.B. Benedek, "Pathological crystallization of human immunoglobulins."Proc. Natl. Acad.Sci. USA, 109, 13359–13361(2012).[PDF]
  12. Y. Wang, A. Lomakin, R.F. Latypov, G.B. Benedek, "Phase separation in solutions of monoclonal antibodies and the effect of human serum albumin" Proc. Natl. Acad.Sci. USA, 108, 16606–16611 (2011).[PDF]
  13. Y. Wang, A. Lomakin, J.J. McManus, O. Ogun, G.B. Benedek, "Phase behavior of mixtures of human lens proteins Gamma D and Beta B1" Proc. Natl. Acad.Sci. USA, 107, 13282–13287 (2010). [PDF]
  14. O. Annunziata, A. Payne and Y. Wang, “Solubility of lysozyme in the presence of aqueous chloride salts: common-ion effect and its role on solubility and crystal thermodynamics.”, J. Am. Chem. Soc., 130, 13347-13352 (2008). [PDF]
  15. Y. Wang and O. Annunziata, “Liquid-liquid phase transition of protein aqueous solutions isothermally induced by protein crosslinking”, Langmuir, 24, 2799-2807 (2008).[PDF]
  16. Y. Wang and O. Annunziata, “Comparison between protein-PEG interactions and the effect of PEG on protein-protein interactions using the liquid-liquid phase transition”, J. Phys. Chem. B, 111, 1222-1230 (2007).[PDF]